awmsg logo



aviptadil/phentolamine (Invicorp®)


Reference No. 2972

Publication date:
28/11/2016


Appraisal information

aviptadil/phentolamine (Invicorp®) 25 micrograms / 2 mg solution for injection


Company: Evolan Pharma AB
BNF category: Obstetrics, gynaecology, and urinary-tract disorders
NMG meeting date: 05/10/2016
AWMSG meeting date: 09/11/2016
   
   
Submission Type: Full Submission
Status: Not recommended
Advice No: 3216
Ministerial ratification: 25/11/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Aviptadil/phentolamine (Invicorp®) is not recommended for use within NHS Wales for the symptomatic treatment of erectile dysfunction in adult males due to neurogenic, vasculogenic, psychogenic, or mixed aetiology. The clinical and cost-effectiveness data presented in the submission were insufficient for AWMSG to recommend its use.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download